Category | Characteristics of participants in study | Number of studies |
---|---|---|
Disease or condition | AUD | 38 |
Drug addiction or smoking ± AUD | 18 | |
Psychiatric disorders ± AUD | 13 | |
Impulse control disorders | 9 | |
Obesity or eating disorders | 6 | |
Inflammatory disorders | 3 | |
malignancies | 2 | |
Target dose of naltrexonea (mg) | ≤4.5 | 5 |
16–49 | 7 | |
50 | 61 | |
100 | 12 | |
>100 | 8 | |
Mean age where givenb (years) | 10 to <20 | 2 |
20 to <30 | 2 | |
30 to <40 | 11 | |
40 to <50 | 62 | |
50 to <60 | 3 | |
≥60 | 2 | |
Length of studyc (weeks) | 4–7 | 5 |
8–11 | 17 | |
12–15 | 42 | |
16–25 | 18 | |
26–52 | 6 |